MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$5,935,900K
Net Income
$782,300K
Net Profit Margin
13.18%
EPS
$7.93
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Service
Revenue Breakdown
    • US
    • Otherforeignlocations
    • IE
Revenue Breakdown
    • Healthcare Segment
    • Applied Sterilization Technologi...
    • Life Science Member

Income Statement
2026-03-31
2025-03-31
2024-03-31
2023-03-31
Total revenues
5,935,900 5,459,515 5,138,701 4,957,839
Product
1,625,500 1,514,275 1,516,082 1,513,970
Service
1,683,900 1,542,476 1,404,459 1,284,177
Cost of revenues
3,309,400 3,056,751 2,920,541 2,798,147
Gross profit
2,626,500 2,402,764 2,218,160 2,159,692
Selling, general, and administrative
1,407,700 1,334,276 1,252,318 1,298,876
Goodwill, impairment loss
NaN NaN NaN 490,565
Research and development
112,900 107,648 103,679 101,581
Litigation settlement, loss
0 48,150 NaN NaN
Restructuring costs
4,100 46,049 26,045 485
Total operating expenses
1,524,700 1,536,123 1,382,042 1,891,507
Income (loss) from operations
1,101,800 866,641 836,118 268,185
Interest expense
NaN NaN 144,351 107,989
Fair value adjustment related to convertible debt liability
NaN NaN 0 0
Interest expense
60,700 86,261 NaN NaN
Interest income and miscellaneous expense
9,800 8,402 11,043 -2,848
Other expense (income), net
-3,500 7,425 NaN NaN
Total non-operating expenses, net
-54,400 -70,434 -133,308 -110,837
Income (loss) before income tax expense (benefit)
1,047,300 796,207 702,810 157,348
Income tax expense (benefit)
262,200 184,650 149,530 51,535
Income from continuing operations, net of income tax
785,100 611,557 553,280 NaN
Product
NaN 63,936 407,027 NaN
Product
NaN 35,146 226,934 NaN
Gross profit
NaN 28,790 180,093 NaN
Selling, general, and administrative
NaN 13,466 199,511 NaN
Goodwill impairment loss
NaN 0 0 NaN
Research and development
NaN 369 2,960 NaN
Income (loss) from operations
NaN 14,955 -22,378 NaN
Non-operating expenses (income), net
NaN 1 10 NaN
Loss on classification as held for sale
NaN 13,995 206,444 NaN
Income (loss) before income tax expense
NaN 959 -228,812 NaN
Income tax benefit
NaN -3,558 -55,611 NaN
Income (loss) from discontinued operations, net of income tax
0 4,517 -173,201 NaN
Net income
785,100 616,074 380,079 105,813
Less net income attributable to noncontrolling interests
2,800 1,433 1,840 -1,217
Net income attributable to shareholders
782,300 614,641 378,239 107,030
Basic EPS
7.97 6.24 3.83 1.07
Diluted EPS
7.93 6.2 3.81 1.07
Basic Average Shares
98,200,000 98,575,000 98,787,000 99,706,000
Diluted Average Shares
98,700,000 99,069,000 99,359,000 100,246,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Product$3,060,100K (6.56%↑ Y/Y)Service$2,875,800K (11.12%↑ Y/Y)Total revenues$5,935,900K (8.73%↑ Y/Y)Gross profit$2,626,500K (9.31%↑ Y/Y)Cost of revenues$3,309,400K (8.27%↑ Y/Y)Income (loss) fromoperations$1,101,800K (27.13%↑ Y/Y)Total operatingexpenses$1,524,700K (-0.74%↓ Y/Y)Service$1,683,900K (9.17%↑ Y/Y)Product$1,625,500K (7.35%↑ Y/Y)Income (loss) beforeincome tax expense...$1,047,300K (31.54%↑ Y/Y)Total non-operatingexpenses, net-$54,400K (22.76%↑ Y/Y)Interest income andmiscellaneous expense$9,800K (16.64%↑ Y/Y)Selling, general, andadministrative$1,407,700K (5.50%↑ Y/Y)Research and development$112,900K (4.88%↑ Y/Y)Restructuring costs$4,100K (-91.10%↓ Y/Y)Income from continuingoperations, net of income tax$785,100K (28.38%↑ Y/Y)Income tax expense(benefit)$262,200K (42.00%↑ Y/Y)Interest expense$60,700K (-29.63%↓ Y/Y)Other expense(income), net-$3,500K (-147.14%↓ Y/Y)Net income$785,100K (27.44%↑ Y/Y)Net incomeattributable to shareholders$782,300K (27.28%↑ Y/Y)Less net incomeattributable to...$2,800K (95.39%↑ Y/Y)

STERIS Annual Report 2022_ANNRPT22

STERIS plc (STE)

STERIS Annual Report 2022_ANNRPT22

STERIS plc (STE)